Potential unblinding in a crossover trial of cannabis cigarettes for relief of neuropathic pain

Mireles, J.R. (2008) Potential unblinding in a crossover trial of cannabis cigarettes for relief of neuropathic pain. Epidemiologic Focus, 1. e4. ISSN 1944-3307

Full text available as:

PDF - Requires Adobe Acrobat Reader or other PDF viewer.
89 Kb

Abstract

Wilsey et al. recently explored the effect of cannabis cigarettes on neuropathic pain. However, the psychoactive side-effects measured as secondary outcomes in this study could have led to the unblinding of study participants. First, all of the participants were previous marijuana smokers. Thus, the participants would likely recognize the effects of marijuana and may be motivated to report positive effects on pain. Second, this study failed to show an effect on antinociception, whereas a separate study indicated a significant dose-dependent antinociception effect. Therefore, unblinding could have contributed to higher participant-reported visual analog scale scores after cannabis administration and resulted in effect estimates that incurred a positive bias away from the null.

EPrint Type:Article
Uncontrolled Keywords:crossover trial, cannabis, neuropathic pain, unblinding, side-effects
Subjects:-Journal Repositories > Epidemiologic Focus
Nervous System Diseases > Neurologic Manifestations > Pain
Pathological Conditions, Signs and Symptoms > Signs and Symptoms > Pain
Central Nervous System Agents > Psychotropic Drugs > Hallucinogens
Environment and Public Health > Public Health > Epidemiologic Methods
Amino Acids, Peptides, and Proteins > Peptides > Oligopeptides
Nervous System Diseases > Neuromuscular Diseases > Peripheral Nervous System Diseases
ID Code:3225
Deposited By:Epidemiologic Focus
Deposited On:27 February 2009

Archive Staff Only: edit this record